The in situ sequencing (ISS) unit provides spatially resolved gene expression data for panels of genes at subcellular resolution. The technique has been developed in the lab of Mats Nilsson who has pioneered the field of generating in situ gene expression and mutation profiles (Ke R et al; 2013 Nature Methods).
In situ sequencing enables localization and quantification of more than 100 transcripts simultaneously with subcellular resolution in a single tissue section per experiment.
Tissue/cell line samples on standard microscopy slides are pre-treated to generate cDNA in situ. A set of genes are targeted with a custom designed padlock probe library. Probes that have specifically interacted with the targeted transcripts are amplified by Rolling Circle Amplification (RCA) reaction, and the specific amplification generates signals with high signal to noise ratio.
Specific barcode sequence in the probe for each targeted gene is decoded by sequential hybridization reaction and imaging cycles. The signals are detected by fluorescently labelled oligonucleotide libraries. ISS can be used to detect up to a few hundred genes per sample. Wide-field imaging enables high throughput.
After image acquisition, images are processed with the analysis pipeline. CSV file is generated for x-y coordinates map of each signal, and each cell nucleus.
New projects from users are assessed with an initial sample screening and a feasibility test.
ISS technology has been successfully demonstrated for a variety of applications such as mapping of
across different types of tissue sections including fresh frozen, PFA-fixed and FFPE.
Interested to know more about insitu sequencing technology? Please contact the unit using this email (firstname.lastname@example.org). We will get back to you shortly to schedule a meeting for further discussion.